Ex-Biogen chief George Scangos to spearhead a Gates-backed startup with big plans to fight infectious diseases
Ex-Biogen CEO George Scangos won’t be spending much time between jobs. Arch Ventures co-founder Robert Nelsen has recruited Scangos to run an ambitious new startup of his focused on amping up an immune system attack on some pernicious viral and bacterial diseases like tuberculosis.
Nelsen, who never does anything small, has already committed $150 million to the venture — dubbed Vir Biotechnology. He’s being joined by the Bill & Melinda Gates Foundation alongside “sovereign wealth funds, public mutual funds and prominent individuals and family offices” that plan to put up hundreds of millions more to back their work.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.